Site Members can sign up for company wide alerts
Investigation Overview
January 19, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), was announced concerning whether the takeover of Ariad Pharmaceuticals, Inc. by Takeda Pharmaceutical Company Limited for $24.00 per share is unfair to NASDAQ:ARIA stockholders. The investigation by a law firm concerns whether ce...
You must register (for free) or login to view the entire investigation.